HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lígia R Rodrigues Selected Research

Proton Pumps (Proton Pump)

12/2022Plasmalemmal V-ATPase as a Potential Biomarker for Lactoferrin-Based Anticancer Therapy.
11/2022Lactoferrin perturbs intracellular trafficking, disrupts cholesterol-rich lipid rafts and inhibits glycolysis of highly metastatic cancer cells harbouring plasmalemmal V-ATPase.
9/2021The milk-derived lactoferrin inhibits V-ATPase activity by targeting its V1 domain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lígia R Rodrigues Research Topics

Disease

17Neoplasms (Cancer)
06/2024 - 06/2007
8Breast Neoplasms (Breast Cancer)
01/2021 - 06/2007
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 06/2007
2Neoplasm Metastasis (Metastasis)
09/2015 - 06/2007
1Carcinoma (Carcinomatosis)
06/2024
1Chronic Obstructive Pulmonary Disease (COPD)
01/2024
1Osteoarthritis
03/2022
1Vitiligo
01/2021
1Mycoses (Diseases, Fungus)
01/2021
1Osteoporosis
01/2021
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2018
1Osteosarcoma (Osteogenic Sarcoma)
01/2018
1Infections
01/2011
1Cross Infection (Nosocomial Infection)
01/2010
1Ovarian Neoplasms (Ovarian Cancer)
06/2007
1Melanoma (Melanoma, Malignant)
06/2007
1Stomach Neoplasms (Stomach Cancer)
06/2007
1Lung Neoplasms (Lung Cancer)
06/2007
1Inflammation (Inflammations)
06/2007

Drug/Important Bio-Agent (IBA)

5LactoferrinIBA
12/2022 - 01/2014
5Adenosine Triphosphatases (ATPase)IBA
12/2022 - 01/2018
4Proteins (Proteins, Gene)FDA Link
06/2024 - 09/2015
4Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2015
3Proton Pumps (Proton Pump)IBA
12/2022 - 09/2021
3Peptides (Polypeptides)IBA
01/2021 - 11/2016
3OsteopontinIBA
09/2017 - 06/2007
2LipidsIBA
11/2022 - 08/2022
2Glycoproteins (Glycoprotein)IBA
11/2022 - 06/2007
2LigandsIBA
04/2022 - 11/2016
1Bacterial DNAIBA
06/2024
1Mitochondrial DNA (mtDNA)IBA
06/2024
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2024
1Folic Acid (Vitamin M)FDA LinkGeneric
06/2024
1ChitosanIBA
06/2024
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2024
1Neoplasm Antigens (Tumor Antigens)IBA
06/2024
1CalreticulinIBA
06/2024
1Tryptophan (L-Tryptophan)FDA Link
01/2024
1AntioxidantsIBA
01/2024
1MelatoninIBA
01/2024
1CholesterolIBA
11/2022
1IronIBA
11/2022
1AcidsIBA
08/2022
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
03/2022
1GlycosaminoglycansIBA
03/2022
1AntibodiesIBA
01/2022
1Furocoumarins (Furanocoumarins)IBA
01/2021
1Volatile Fatty AcidsIBA
01/2020
1IonsIBA
06/2019
1Anti-Bacterial Agents (Antibiotics)IBA
06/2019
1MetalsIBA
06/2019
1A-Form DNA (A-DNA)IBA
09/2017
1ClaudinsIBA
11/2016
1bafilomycin A1IBA
01/2016
1concanamycin AIBA
01/2016
1Proton-Translocating ATPases (ATPase, H+)IBA
01/2016
1Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA
01/2016
1Proton Pump InhibitorsIBA
01/2016
1Surface-Active Agents (Surfactants)IBA
12/2013
1GlycolipidsIBA
12/2013
1LipopeptidesIBA
12/2013
1Biocompatible Materials (Biomaterials)IBA
01/2011
1Synthetic DrugsIBA
01/2010
1Tumor Biomarkers (Tumor Markers)IBA
06/2007

Therapy/Procedure

9Therapeutics
06/2024 - 12/2013
1Drug Therapy (Chemotherapy)
06/2024
1Immunomodulation
06/2024
1Immunotherapy
06/2024
1Oral Administration
01/2024